Cargando…
Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269903/ https://www.ncbi.nlm.nih.gov/pubmed/31471571 http://dx.doi.org/10.1038/s41409-019-0657-3 |
| _version_ | 1783541822255005696 |
|---|---|
| author | Hill, Brian T. Roberts, Zachary J. Xue, Allen Rossi, John M. Smith, Mitchell R. |
| author_facet | Hill, Brian T. Roberts, Zachary J. Xue, Allen Rossi, John M. Smith, Mitchell R. |
| author_sort | Hill, Brian T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7269903 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72699032020-06-15 Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma Hill, Brian T. Roberts, Zachary J. Xue, Allen Rossi, John M. Smith, Mitchell R. Bone Marrow Transplant Correspondence Nature Publishing Group UK 2019-08-30 2020 /pmc/articles/PMC7269903/ /pubmed/31471571 http://dx.doi.org/10.1038/s41409-019-0657-3 Text en © Springer Nature Limited 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Hill, Brian T. Roberts, Zachary J. Xue, Allen Rossi, John M. Smith, Mitchell R. Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title | Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title_full | Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title_fullStr | Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title_full_unstemmed | Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title_short | Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma |
| title_sort | rapid tumor regression from pd-1 inhibition after anti-cd19 chimeric antigen receptor t-cell therapy in refractory diffuse large b-cell lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269903/ https://www.ncbi.nlm.nih.gov/pubmed/31471571 http://dx.doi.org/10.1038/s41409-019-0657-3 |
| work_keys_str_mv | AT hillbriant rapidtumorregressionfrompd1inhibitionafteranticd19chimericantigenreceptortcelltherapyinrefractorydiffuselargebcelllymphoma AT robertszacharyj rapidtumorregressionfrompd1inhibitionafteranticd19chimericantigenreceptortcelltherapyinrefractorydiffuselargebcelllymphoma AT xueallen rapidtumorregressionfrompd1inhibitionafteranticd19chimericantigenreceptortcelltherapyinrefractorydiffuselargebcelllymphoma AT rossijohnm rapidtumorregressionfrompd1inhibitionafteranticd19chimericantigenreceptortcelltherapyinrefractorydiffuselargebcelllymphoma AT smithmitchellr rapidtumorregressionfrompd1inhibitionafteranticd19chimericantigenreceptortcelltherapyinrefractorydiffuselargebcelllymphoma |